These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
327 related items for PubMed ID: 27211551
1. Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study. Pasquier E, André N, Street J, Chougule A, Rekhi B, Ghosh J, Philip DSJ, Meurer M, MacKenzie KL, Kavallaris M, Banavali SD. EBioMedicine; 2016 Apr; 6():87-95. PubMed ID: 27211551 [Abstract] [Full Text] [Related]
2. Metronomic therapy has low toxicity and is as effective as current standard treatment for recurrent high-risk neuroblastoma. Berthold F, Hömberg M, Proleskovskaya I, Mazanek P, Belogurova M, Ernst A, Sterba J. Pediatr Hematol Oncol; 2017 Aug; 34(5):308-319. PubMed ID: 29148865 [Abstract] [Full Text] [Related]
3. Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma. Banavali S, Pasquier E, Andre N. Ecancermedicalscience; 2015 Aug; 9():499. PubMed ID: 25624880 [Abstract] [Full Text] [Related]
4. Metronomic Maintenance With Weekly Vinblastine After Induction With Bevacizumab-Irinotecan in Children With Low-grade Glioma Prevents Early Relapse. Roux C, Revon-Rivière G, Gentet JC, Verschuur A, Scavarda D, Saultier P, Appay R, Padovani L, André N. J Pediatr Hematol Oncol; 2021 Jul 01; 43(5):e630-e634. PubMed ID: 33235152 [Abstract] [Full Text] [Related]
5. Effective treatment of advanced human melanoma metastasis in immunodeficient mice using combination metronomic chemotherapy regimens. Cruz-Munoz W, Man S, Kerbel RS. Clin Cancer Res; 2009 Aug 01; 15(15):4867-74. PubMed ID: 19622578 [Abstract] [Full Text] [Related]
6. Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors. Vogt T, Hafner C, Bross K, Bataille F, Jauch KW, Berand A, Landthaler M, Andreesen R, Reichle A. Cancer; 2003 Nov 15; 98(10):2251-6. PubMed ID: 14601096 [Abstract] [Full Text] [Related]
9. Preliminary evaluation of children treated with metronomic chemotherapy and valproic acid in a low-income country: Metro-Mali-02. Traore F, Togo B, Pasquier E, Dembélé A, André N. Indian J Cancer; 2013 Nov 15; 50(3):250-3. PubMed ID: 24061467 [Abstract] [Full Text] [Related]
15. Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of response. Wong NS, Buckman RA, Clemons M, Verma S, Dent S, Trudeau ME, Roche K, Ebos J, Kerbel R, Deboer GE, Sutherland DJ, Emmenegger U, Slingerland J, Gardner S, Pritchard KI. J Clin Oncol; 2010 Feb 10; 28(5):723-30. PubMed ID: 20026801 [Abstract] [Full Text] [Related]
19. Use of metronomic chemotherapy in oncology: results from a national Italian survey. Collovà E, Sebastiani F, De Matteis E, Generali D, Aurilio G, Boccardo F, Crispino S, Cruciani G. Tumori; 2011 Feb 10; 97(4):454-8. PubMed ID: 21989433 [Abstract] [Full Text] [Related]